| |
 |
Regulation of the Endoplasmic Reticulum Ca2+-Store in Cancer
 |
| |
|
pp.705-709 (5) Authors: A. Bergner, R. M. Huber |
| |
|
|
| |
|
Targeting RSK: An Overview of Small Molecule Inhibitors
|
| |
|
pp.710-716 (7) Author: Tam Luong Nguyen |
| |
|
|
| |
|
A Potent Anti-Carcinoma and Anti-Acute Myeloblastic Leukemia Agent, AG490
|
| |
|
pp.717-722 (6) Author: Julio R. Caceres-Cortes |
| |
|
|
| |
|
Cancer Therapy: Targeting Cell Cycle Regulators
|
| |
|
pp.723-731 (9) Authors: Martin Johansson, Jenny Liao Persson |
| |
|
|
| |
|
Recent Developments of Steroid Sulfatase Inhibitors as Anti-Cancer Agents
|
| |
|
pp.732-738 (7) Authors: Paul A. Foster, Michael J. Reed, Atul Purohit |
| |
|
|
| |
|
Novel Diaryl or Heterocyclic Sulfonamides as Antimitotic Agents
|
| |
|
pp.739-745 (7) Authors: Laixing Hu, Zhuo-rong Li, Jian-dong Jiang, David W. Boykin |
| |
|
|
| |
|
Recent Advances in Lamellarin Alkaloids: Isolation, Synthesis and Activity
|
| |
|
pp.746-760 (15) Authors: D. Pla, F. Albericio, M. Alvarez |
| |
|
|
| |
|
Recent Advances in Hsp90 Inhibitors as Antitumor Agents
|
| |
|
pp.761-782 (22) Authors: S. Messaoudi, J. F. Peyrat, J. D. Brion, M. Alami |
| |
|
|
| |
|
2-Chloroadenosine and Human Prostate Cancer Cells
|
| |
|
pp.783-789 (7) Authors: I. Bellezza, A. Tucci, A. Minelli |
| |
|
|
| |
|
Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression
|
| |
|
pp.790-797 (8) Authors: Jean-Philippe Cosse, Carine Michiels |
| |
|
|
| |
|
Protein Kinase CK2 Inhibitors: Emerging Anticancer Therapeutic Agents?
|
| |
|
pp.798-806 (9) Authors: Andrea Bortolato, Giorgio Cozza, Stefano Moro |
| |
|
|
| |
|
Dimeric Approaches to Anti-Cancer Chemotherapeutics
|
| |
|
pp.807-816 (10) Authors: M. K. Hadden, B. S.J. Blagg |
| |
|
|
